ENDRA LIFE SCIENCES INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENDRA LIFE SCIENCES INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $93.94K, a 89.04% decline year-over-year.
- ENDRA LIFE SCIENCES INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $263.75K, a 217.59% increase year-over-year.
- ENDRA LIFE SCIENCES INC. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $65.56K.
- ENDRA LIFE SCIENCES INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $149.47K.
- ENDRA LIFE SCIENCES INC. stock issued during period, value, new issues for fiscal 2025 was $1.22M, a 6.08% increase from fiscal 2024.
- ENDRA LIFE SCIENCES INC. stock issued during period, value, new issues for fiscal 2024 was $1.15M, a 82.29% decline from fiscal 2023.
- ENDRA LIFE SCIENCES INC. stock issued during period, value, new issues for fiscal 2023 was $6.48M.
- ENDRA LIFE SCIENCES INC. stock issued during period, value, new issues for fiscal 2017 was $7.43M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $93.94K 10-Q · filed 2026-08-14 | $572.71K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $263.75K 10-Q · filed 2026-05-15 | $1.34M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $65.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.22M 10-K · filed 2026-03-31 |
| 2025-09-30 | $149.47K 10-Q · filed 2025-11-14 | $1.09M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $857.41K 10-Q · filed 2026-08-14 | $940.46K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $83.05K 10-Q · filed 2026-05-15 | $811.55K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.15M 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | |
| 2024-06-30 | $728.50K 10-Q · filed 2024-08-14 | |
| 2023-12-31 | $656.81K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-04-07 | $6.48M 10-K/A · filed 2025-04-07 |
| 2023-09-30 | $1.11M 10-Q/A · filed 2024-11-21 | |
| 2023-06-30 | $4.71M 10-Q · filed 2024-08-14 | |
| 2021-03-31 | $9.80M 10-Q · filed 2021-05-17 | |
| 2020-09-30 | $530.42K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $791.47K 10-Q · filed 2020-08-14 | |
| 2017-12-31 | $7.43M 10-K · filed 2019-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |